BrainsWay Ltd

BWAY

Company Profile

  • Business description

    BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

  • Contact

    16 Hartum Street
    14th Floor, RAD Tower
    Har HaHotzvim
    Jerusalem9777516
    ISR

    T: +972 25824030

    https://www.brainsway.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    120

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,820.306.40-0.07%
CAC 407,826.3175.94-0.96%
DAX 4024,244.77212.04-0.87%
Dow JONES (US)44,344.45306.19-0.69%
FTSE 1008,935.8239.84-0.44%
HKSE24,139.57111.200.46%
NASDAQ20,585.0145.65-0.22%
Nikkei 22539,569.6876.68-0.19%
NZX 50 Index12,686.6873.52-0.58%
S&P 5006,254.6625.80-0.41%
S&P/ASX 2008,580.109.10-0.11%
SSE Composite Index3,510.180.500.01%

Market Movers